407634-06-4 Usage
Uses
Used in Pharmaceutical Industry:
1-(3-Methoxypropyl)-5-oxo-3-pyrrolidinecarboxylic acid is used as an intermediate in the synthesis of various pharmaceuticals for its ability to contribute to the development of new drugs and enhance the properties of existing ones.
Used in Organic Chemistry:
In the field of organic chemistry, 1-(3-Methoxypropyl)-5-oxo-3-pyrrolidinecarboxylic acid is utilized as a building block for the creation of complex organic compounds, facilitating the synthesis of novel molecules with potential applications in various domains.
Used in Chemical Industry:
1-(3-Methoxypropyl)-5-oxo-3-pyrrolidinecarboxylic acid is employed in the chemical industry as a key component in the production of specialty chemicals, contributing to the advancement of chemical processes and the development of innovative products.
Check Digit Verification of cas no
The CAS Registry Mumber 407634-06-4 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 4,0,7,6,3 and 4 respectively; the second part has 2 digits, 0 and 6 respectively.
Calculate Digit Verification of CAS Registry Number 407634-06:
(8*4)+(7*0)+(6*7)+(5*6)+(4*3)+(3*4)+(2*0)+(1*6)=134
134 % 10 = 4
So 407634-06-4 is a valid CAS Registry Number.
407634-06-4Relevant academic research and scientific papers
CYCLIC AMINE BASE-1 INHIBITORS HAVING A HETEROCYCLIC SUBSTITUENT
-
Page/Page column 29, (2008/06/13)
Disclosed are novel compounds of the formula (I)or a pharmaceutically acceptable salt or solvate thereof, wherein R1 is formula (I) X is -0-, -C(R14)2- or -N(R)-; Z is -C(R14)2- or -N(R)-; t is 0, 1, 2 or 3; each R and R2 is independently H, alkyl, cycloalkyl, cycloalkylalkyl, aryl, heteroaryl, heterocycloalkyl, arylalkyl, heteroarylalkyl, heterocycloalkylalkyl, alkenyl or alkynyl; each R14 is H, alkyl, alkenyl, alkynyl, halo, -CN, haloalkyl, cycloalkyl, cycloalkylalkyl, aryl, heteroaryl, heterocycloalkyl, arylalkyl, heteroarylalkyl, heterocycloalkylalkyl, -OR35, -N(R24)(R25)or -SR35; R41 is alkyl, cycloalkyl, -S02(alkyl), -C(O)-alkyl, -C(O)-cycloalkyl or -alkyl-NH-C(O)CH3; and the remaining variables are as defined in the specification. Also disclosed are pharmaceutical compositions comprising the compounds of formula I and methods of treating cognitive or neurodegenerative diseases with compounds of formula (I). Also disclosed are pharmaceutical compositions and methods of treatment comprising compounds of formula I in combination with other agents useful in treating cognitive or neurodegenerative diseases.
